Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Luzia Veletzky, Spinello Antinori, Sabine Bélard, Marielle Bouyou, Emmanuel Bottieau, Jérémy T Campillo, Cédric B Chesnais, Fernando de la Calle-Prieto, Federico Gobbi, Marc P Hübner, Amy D Klion, Pia Michelitsch, Andreas Neumayr, Tamara Nordmann, Thomas B Nutman, Fernando Salvador, Stephen D Vaughan, Michael Ramharter, Francesca Tamarozzi
Expert consensus on case definitions in human loiasis: a Delphi study. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926002409?dgcid=rss_sd_all
Expert consensus on case definitions in human loiasis: a Delphi study. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926002409?dgcid=rss_sd_all
“Expert consensus on case definitions in human loiasis: a Delphi study.” The Lancet Infectious Diseases.
@article{article101638,
title = {Expert consensus on case definitions in human loiasis: a Delphi study},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926002409?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...